Celldex Therapeutics, Inc. presented final results yesterday from a Phase 1 study of CDX-301 in healthy volunteers that strongly support the initiation of a pilot study in hematopoietic stem cell transplantation later this year.
http://www.globenewswire.com/news-release/2013/02/14/523630/10021811/en/Positive-Data-From-Celldex-s-Phase-1-Study-of-CDX-301-Support-Initiation-of-Pilot-Study-in-Hematopoietic-Stem-Cell-Transplantation.html
http://www.globenewswire.com/news-release/2013/02/14/523630/10021811/en/Positive-Data-From-Celldex-s-Phase-1-Study-of-CDX-301-Support-Initiation-of-Pilot-Study-in-Hematopoietic-Stem-Cell-Transplantation.html
No comments:
Post a Comment